Matthew Caldemeyer
- Role
- Chief Business Officer at Recludix Pharma
- Location
- Golden, CO, US
- LinkedIn followers
- 500 followers
About Matthew Caldemeyer
Business development professional with progressive buy and sell side experience in the…
Experience
Chief Business Officer
Sep 2022 — Present
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets including the development of novel SH2 domain inhibitors. Recludix’s most advanced programs are focused on Signal Transducer and Activator of Transcription (STAT) proteins - STAT3 and STAT6 - where abnormal activation is found in numerous cancer types, such as multiple leukemias and lymphomas, as well as inflammatory diseases, such as rheumatoid arthritis, asthma, atopic dermatitis, inflammatory bowel disease, and others.
Education
Indiana University - Kelley School of Business
Master of Business Administration - MBA, Finance
Michigan State University
Bachelor of Science - BS
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.